Medicare Enrolled
Dr. Amy Woodruff, M.D.
Cardiovascular Disease · Houston, TX
Practice pattern: Remote & Cardiac— Practice combining remote and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Woodruff from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Woodruff? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Woodruff
Dr. Amy Woodruff is a cardiovascular disease in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Woodruff performed 6,237 Medicare services across 2,938 unique beneficiaries.
Between the years covered by Open Payments, Dr. Woodruff received a total of $27,811 from 56 pharmaceutical and/or device companies across 720 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Woodruff is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 10% volume in TX$ $27,811 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,237
Medicare services
Top 10% in TX for cardiovascular disease
2,938
Unique beneficiaries
$109
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~328 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 1,190 | $27 | $111 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 1,160 | $19 | $131 |
| Regadenoson injection (Lexiscan) for heart stress test | 738 | $44 | $138 |
| Electrocardiogram (EKG), 12-lead | 544 | $10 | $150 |
| Office visit, established patient (30-39 min) | 477 | $94 | $247 |
| Echocardiogram, transthoracic | 295 | $144 | $975 |
| Remote pacemaker/defibrillator monitoring, 90 days | 259 | $16 | $80 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 223 | $55 | $325 |
| Ultrasound of both sides of head and neck blood flow | 207 | $148 | $597 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 185 | $1,058 | $4,500 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 185 | $622 | $1,552 |
| Remote pacemaker monitoring, 90 days | 180 | $21 | $99 |
| Office visit, established patient (20-29 min) | 82 | $61 | $165 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 79 | $25 | $120 |
| Hospital follow-up visit, low complexity | 76 | $40 | $276 |
| New patient office visit (45-59 min) | 52 | $121 | $380 |
| Hospital follow-up visit, moderate complexity | 49 | $64 | $278 |
| Programming of dual lead pacemaker system | 45 | $58 | $224 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 32 | $19 | $89 |
| Hospital follow-up visit, high complexity | 30 | $96 | $276 |
| Office visit, established patient, complex (40-54 min) | 29 | $139 | $332 |
| Insertion of heart rhythm monitor under skin | 26 | $3,521 | $15,464 |
| New patient office visit, complex (60-74 min) | 22 | $173 | $485 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 16 | $20 | $86 |
| Programming of dual lead implantable defibrillator system | 16 | $77 | $287 |
| Programming of single lead pacemaker system | 15 | $52 | $165 |
| External shock to heart to regulate heart beat | 13 | $87 | $521 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 12 | $677 | $3,025 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.3% high complexity
21.7% medium
64.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$27,811
Total received (2018-2024)
Avg $3,973/year across 7 years
Top 16% in TX for cardiovascular disease
56
Companies
720
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,408 (62.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$10,403 (37.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$12,154
2023$3,036
2022$2,959
2021$2,111
2020$1,483
2019$3,375
2018$2,694
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$11,525
Impulse Dynamics (USA) Inc.
$2,200
Medtronic Vascular, Inc.
$2,106
Janssen Pharmaceuticals, Inc
$1,337
E.R. Squibb & Sons, L.L.C.
$932
Medtronic, Inc.
$928
Abbott Laboratories
$916
PFIZER INC.
$876
Amarin Pharma Inc.
$849
SANOFI-AVENTIS U.S. LLC
$709
Esperion Therapeutics, Inc.
$672
Novartis Pharmaceuticals Corporation
$584
AstraZeneca Pharmaceuticals LP
$388
Merck Sharp & Dohme LLC
$292
Gilead Sciences, Inc.
$291
Akcea Therapeutics, Inc.
$271
Boehringer Ingelheim Pharmaceuticals, Inc.
$253
HeartFlow, Inc.
$211
AltaThera Pharmaceuticals LLC
$206
BOSTON SCIENTIFIC CORPORATION
$165
ATRICURE, INC.
$159
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$155
Novo Nordisk Inc
$125
Astellas Pharma US Inc
$117
Regeneron Healthcare Solutions, Inc.
$111
Bayer Healthcare Pharmaceuticals Inc.
$109
HEARTFLOW, INC.
$92
ARBOR PHARMACEUTICALS, INC.
$90
Boston Scientific Corporation
$87
BIOTRONIK INC.
$84
Alnylam Pharmaceuticals Inc.
$82
Kowa Pharmaceuticals America, Inc.
$81
Kiniksa Pharmaceuticals International, plc
$71
Lexicon Pharmaceuticals, Inc.
$63
Inspire Medical Systems, Inc.
$57
iRhythm Technologies, Inc.
$57
Biosense Webster, Inc.
$48
CARDIVA MEDICAL, INC.
$47
Azurity Pharmaceuticals, Inc.
$47
G Medical Diagnostic Services, Inc.
$42
AngioDynamics, Inc.
$41
ARALEZ PHARMACEUTICALS US INC.
$38
Arbor Pharmaceuticals, Inc.
$36
MEDICOMP INC
$35
Eisai Inc.
$35
LEO Pharma Inc.
$24
Lundbeck LLC
$23
Kestra Medical Technology Services, Inc.
$20
Daiichi Sankyo Inc.
$20
Actelion Pharmaceuticals US, Inc.
$18
Preventice Services, LLC
$18
Otsuka America Pharmaceutical, Inc.
$17
Tactile Systems Technology Inc
$16
Baylis Medical Company Inc
$15
Baxter Healthcare
$14
Aziyo Biologics, Inc.
$10
Top 3 companies account for 56.9% of total payments
Associated products mentioned in payments ›
ADBRY · AVIVO · AZURE XT DR MRI SURESCAN · Advisa · Arcalyst · Assure WCD · Assurity Pacemaker · Azure · BRILINTA · CAMZYOS · CARDIAC MONITOR · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CHANTIX · COBALT DR MRI SURESCAN · Cardiac Monitoring Suite · CareLink · CareLink Express · Cobalt · Corlanor · CryoConsole · Dayvigo · ECM · EDARBI · ELIQUIS · ENSITE PRECISION · ENSTILAR · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Edarbyclor · Ellipse ICD · FARXIGA · FFRct · Flexitouch Plus · Fortify Assura · General - Therapies · HORIZANT · Hillrom - Cardiac Ambulatory Monitor · Horizant · INJECTAFER · INSPIRE · Inpefa · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LINQ II · LIVALO · LifeVest · Livalo · MULTAQ · Merlin Connectivity and Remote · Micra · Mitra Clip system · MitraClip System · NA · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer · Optimizer Smart System · Ozempic · PERCLOSE PROSTYLE · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PULSESELECT · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · REVEAL LINQ · Repatha · Reveal LINQ · SAMSCA · SelectSecure · Sotalol Hydrochloride · TEGSEDI · Tendril Pacing Lead · VERQUVO · VYNDAQEL · Vascepa · VersaCross Access Solution · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · ZIO Patch · ZIO XT Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (63%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $446 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
385
Per 100K population
8.1
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Woodruff is a remote & cardiac specialist, with above-average Medicare volume (top 10% in TX), and high industry engagement (low-engagement, top 16%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Woodruff experienced with interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec?
Based on Medicare claims data, Dr. Woodruff performed 1,190 interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Woodruff receive payments from pharmaceutical companies?
Yes. Dr. Woodruff received a total of $27,811 from 56 companies across 720 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Woodruff's costs compare to other cardiovascular diseases in Houston?
Dr. Woodruff's average Medicare payment per service is $109. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Woodruff) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Houston
Browse cardiovascular diseases in Houston ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Impulse Dynamics (USA) Inc. Payments to Doctors
See all physicians who received payments from Impulse Dynamics (USA) Inc..
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology